Erasca, Inc. (ERAS)
13.61
-0.61
(-4.29%)
USD |
NASDAQ |
Nov 20, 16:00
13.74
+0.13
(+0.96%)
After-Hours: 20:00
Erasca Net Income (Quarterly) : -51.33M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -51.33M |
| June 30, 2026 | -44.08M |
| March 31, 2026 | -183.44M |
| December 31, 2025 | -29.09M |
| September 30, 2025 | -30.61M |
| June 30, 2025 | -33.88M |
| March 31, 2025 | -30.97M |
| December 31, 2024 | -32.23M |
| September 30, 2024 | -31.20M |
| June 30, 2024 | -63.20M |
| March 31, 2024 | -35.02M |
| December 31, 2023 | -29.70M |
| September 30, 2023 | -30.36M |
| June 30, 2023 | -31.78M |
| Date | Value |
|---|---|
| March 31, 2023 | -33.20M |
| December 31, 2022 | -135.25M |
| September 30, 2022 | -35.49M |
| June 30, 2022 | -35.61M |
| March 31, 2022 | -36.46M |
| December 31, 2021 | -30.46M |
| September 30, 2021 | -46.07M |
| June 30, 2021 | -28.21M |
| March 31, 2021 | -18.02M |
| December 31, 2020 | -61.90M |
| September 30, 2020 | -10.61M |
| June 30, 2020 | -5.491M |
| March 31, 2020 | -23.66M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -20.62M |
| Revolution Medicines, Inc. | -407.46M |
| Immunome, Inc. | -85.78M |
| Tango Therapeutics, Inc. | -68.39M |
| Oncolytics Biotech, Inc. | -9.705M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 51.33M |
| EPS Diluted (Quarterly) | -0.1491 |
| Enterprise Value | 4.166B |
| Earnings Yield | -7.32% |
| Normalized Earnings Yield | -4.782 |